Validation of a Predictive Rule for the Diagnosis of Viral Meningitis in Adult Emergency Departments
Adult-BMS
1 other identifier
observational
1,000
1 country
1
Brief Summary
Meningitis is the development of an inflammatory reaction in the meningeal space, most often of infectious origin. Many pathogens can cause meningitis, the severity of which varies greatly. Patients presenting with a febrile meningeal syndrome are most often managed in the emergency room, where the challenge for physicians is to quickly differentiate bacterial and viral meningitis. Viral meningitis is the most common, with enterovirus meningitis having a classically excellent prognosis. Bacterial meningitis is less frequent but more serious.The current public health objective is to save antibiotics. Investigator hypothesizes that the BMS score can be used to exclude bacterial meningitis in the emergency department in an adult European population of patients with suspected bacterial meningitis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2021
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 26, 2021
CompletedFirst Submitted
Initial submission to the registry
September 21, 2021
CompletedFirst Posted
Study publicly available on registry
September 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 26, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 26, 2022
CompletedJanuary 24, 2022
September 1, 2021
1 year
September 21, 2021
January 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
External validation of the BMS score in a European adult population to exclude bacterial meningitis
Validation was measured by comparaison between BMS score and the diagnosis retained from the data collected in the file
1 month after inclusion
Eligibility Criteria
The study population will be extracted from the population having consulted the Adult Emergency Departments of the Le Mans Hospital, the Angers and Nantes University Hospitals and the Beaujon University Hospital between January 1, 2009 and December 31, 2020 and for whom a lumbar puncture will have been performed for suspected meningitis.
You may qualify if:
- Patient admitted to the Adult Emergency Department of CH Le Mans,CHU Angers, CHU Nantes or Beaujon Hospital.
- Over 18 years old
- Having had a lumbar puncture during their stay in the Adult Emergency Department
- Having had a diagnosis of meningitis defined as a pleocytosis ≥ 5leukocytes/mm3 after correction with CSF red blood cells at a standardized ratio of 500/1.
You may not qualify if:
- Immunosuppression from any cause
- Presence of petechiae or purpura
- History of recent neurosurgery or head trauma
- Other associated bacterial infection
- Inability to collect information for the BMS score calculation or primary endpoint (e.g., transfer to another facility)
- Minor or adult patient under guardianship or protection
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Centre Hospitalier Du Mans
Le Mans, 72000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 21, 2021
First Posted
September 30, 2021
Study Start
August 26, 2021
Primary Completion
August 26, 2022
Study Completion
August 26, 2022
Last Updated
January 24, 2022
Record last verified: 2021-09